Evidence map›Paper›PMID 42470596›Full record

ArticleProbiotics and antimicrobial proteins2026

Artificial Intelligence and Protein Design: A retrospective study on 20-year emerging trends and core research areas from bibliometric perspectives.

Wenjuan Zhao, Xiuwu Pan, Wei Yang, Zichang Liu, Xiyi Wei, Anqi Lin, Bufu Tang, Lin Zhang, Mingjia Xiao, Qing Zeng and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Wenjuan Zhao *Department of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Xiuwu Pan *Department of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Wei Yang *Department of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Zichang Liu *Department of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Xiyi WeiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Anqi LinDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China, Cancer Centre and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, China.
Bufu TangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Lin ZhangThe School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3000, Australia.
Mingjia XiaoHepatobiliary Surgery Department, Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
Qing ZengCenter of Rehabilitation Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Quan ChengDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Weiming MouDepartment of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xiaofan LuDepartment of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, 67400, Illkirch, France.
Kai MiaoCancer Centre, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, China. kaimiao@um.edu.mo.
Peng LuoDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China, Cancer Centre and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, China. luopeng@smu.edu.cn.
Xin-Gang CuiDepartment of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China. cuixingang@xinhuamed.com.cn.ORCID http://orcid.org/0000-0002-0920-9439
Wen-Jin ChenDepartment of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China. chenwenjin@shsmu.edu.cn.

Funding

National Natural Science Foundation of China 82503372
6 · The paper itself

Abstract

Protein design has numerous applications in synthetic biology, drug discovery, and bioengineering. Recently, there has been a revolution in this field due to the emergence of artificial intelligence. At the forefront are deep learning models (DLMs). The impact of these models on the design pipeline is so transformative that it leads to radical advances in prediction accuracy, functional enrichment, and de novo synthesis of proteins. We performed bibliometric analysis on a Web of Science data-set (2006-2025) obtained through a targeted keyword search. Our analysis method orchestrated the use of standard tools such as CiteSpace and VOSviewer for co-citation, keyword co-occurrence, and burst detection, while we used custom python scripts to generate more nuanced plots for collaboration networks and intellectual overlap. Based on the bibliometric analysis, we observe a sudden jump in publication counts after the year 2018. This period also coincides with the publication of many methodological breakthroughs such as AlphaFold2 and RoseTTAFold. The analysis revealed three major intellectual clusters focused around protein structure prediction, directed evolution, and de novo design of proteins. DLMs play a major role in the publication impact of generating functional protein sequences, with frameworks such as ProteinMPNN having a notable citation footprint. Although China and the United States dominated in raw publication volume, citation impact told a different story-Switzerland ranked second in per-publication influence, suggesting that research programs combining computational design with systematic experimental validation tend to generate disproportionate scholarly impact. International collaborative efforts were notable after 2020. Citation and co-citation analysis highlighted works that have formed the bedrock of this field. Notable mentions include seminal works on AlphaFold2, ProteinMPNN, and RFdiffusion. Protein design stands at the center of an AI revolution that has drawn database mining, computational generation, and experimental validation into an increasingly rapid and interconnected engineering loop. Yet sustaining this momentum requires confronting limitations that the field's most cited literature has largely left unspoken: models trained on stable, crystallizable structures struggle to generalize beyond their training distributions, static predictions remain blind to the conformational dynamics governing allostery and catalysis, and in silico confidence scores have repeatedly proven poor predictors of wet-lab outcomes. Closing this gap will demand not incremental refinement but the sustained, bidirectional coupling of high-throughput experimental feedback with iterative design-test-learn cycles, supported by next-generation models that natively represent PTMs, cellular context, and conformational ensembles-a convergence that holds genuine promise for translating the field's computational ambitions into reliable therapeutic and synthetic biology outcomes.

Indexed as

Artificial IntelligenceBibliometric AnalysisDe Novo DesignDirected EvolutionProtein DesignStructure Prediction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.